MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 157 filers reported holding MOMENTA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $14,972,000 | -72.5% | 450,000 | -77.5% | 0.86% | -73.6% |
| Q1 2020 | $54,400,000 | -15.2% | 2,000,000 | -38.5% | 3.25% | -0.5% |
| Q4 2019 | $64,123,000 | +41.4% | 3,250,000 | -7.1% | 3.26% | +36.8% |
| Q3 2019 | $45,360,000 | +4.1% | 3,500,000 | 0.0% | 2.38% | +17.4% |
| Q2 2019 | $43,575,000 | -25.0% | 3,500,000 | -12.5% | 2.03% | -29.9% |
| Q1 2019 | $58,120,000 | +31.6% | 4,000,000 | 0.0% | 2.90% | +38.2% |
| Q4 2018 | $44,160,000 | -41.7% | 4,000,000 | +38.9% | 2.10% | -35.3% |
| Q3 2018 | $75,715,000 | +21.2% | 2,878,890 | -5.8% | 3.24% | +34.8% |
| Q2 2018 | $62,475,000 | +2443.8% | 3,055,000 | +2157.9% | 2.40% | +1886.8% |
| Q1 2018 | $2,456,000 | -47.3% | 135,300 | -66.2% | 0.12% | -66.8% |
| Q1 2014 | $4,660,000 | -67.1% | 400,000 | -50.0% | 0.36% | -70.8% |
| Q4 2013 | $14,144,000 | +22.9% | 800,000 | 0.0% | 1.25% | +3.4% |
| Q3 2013 | $11,512,000 | -4.4% | 800,000 | 0.0% | 1.21% | -2.6% |
| Q2 2013 | $12,048,000 | – | 800,000 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MONROE HALL ASSET MANAGEMENT LLC | 200,000 | $3,282,000 | 1.60% |
| SECTOR GAMMA AS | 350,920 | $5,759,000 | 1.56% |
| Opaleye Management Inc. | 160,000 | $2,626,000 | 1.29% |
| Visium Asset Management, LP | 5,398,088 | $88,583,000 | 1.21% |
| Palo Alto Investors LP | 1,455,176 | $23,879,000 | 1.15% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 4,597,915 | $75,452,000 | 0.84% |
| Sivik Global Healthcare LLC | 90,000 | $1,477,000 | 0.72% |
| Campbell & CO Investment Adviser LLC | 45,887 | $753,000 | 0.50% |
| Apex Capital Management | 1,096,757 | $17,998,000 | 0.41% |
| AlphaMark Advisors, LLC | 42,651 | $700,000 | 0.39% |